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KEYNOTE ADDRESS: ENGINEERING EDEN:
INVESTIGATING THE LEGAL AND ETHICAL
DILEMMAS OF MODERN BIOTECHNOLOGY
JOHN D. MURNANE, EsQ.*
Good afternoon. Thank you very much, Professor. I
compliment St. John's Law School and the University for hosting
this program. I am grateful to Eleanor Hynes and Paul Maier,
and the staff of the St. John's Journal of Legal Commentary for
inviting me to speak here this afternoon at their twelfth annual
symposium. It is good to be back in the neighborhood. Twenty
years ago last month, my wife Terri and I moved to this
neighborhood with our then-infant son Austin. He is now twenty
years old and in his third year at the United States Naval
Academy at Annapolis, Maryland. Thank you. I'll tell him you
gave him that round of applause.
While we lived in nearby Holliswood between 1985 and 1992,
our other three children were born. When we first moved into
our home on 191st Street it needed painting, so I started doing it.
One day while I was painting the top of the front of the house I
heard a woman call, "Young man." I turned and saw a beautifully
dressed older woman, across the street, on the arm of a nicely
dressed younger woman. The older woman curved her finger
beckoning me as she once again said, "Young man." I climbed
down the ladder, crossed the street, and said, "Hello." She asked,
'Young man, what are you getting for painting that house?" I told
her, "I get to stay with the lady inside." The younger one then
said, ' You're hired."
I learned to paint when I was a teenager in Albany, New York,
where I grew up. During high school and college vacations, I
Partner, Fitzpatrick, Cella, Harper & Scinto. These remarks are an actual transcript
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painted houses. One summer, I got a job painting the bridges on
those new superhighways which lead into downtown Albany. On
my first day on the job, while I was way up underneath one of the
bridges, I heard a voice calling me, "John Murnane, get off that
bridge this instant." I looked down and there was my
grandmother, standing in construction rubble in her high heels,
pocketbook on her arm, wearing white gloves. She yelled again,
"John Murnane, get off that bridge." I explained to her that I
could not get down because I had to wait for ropes and a ladder to
be delivered and she said, "I'll pay you what they're paying you
not to do that." I responded that they were paying me eight
dollars an hour. She paused and replied, "Be very careful up
there."
Painting was something that I enjoyed, but I thought that
practicing law may be easier - so I went to law school. I have
been a patent attorney for about twenty-six years. For seven of
those years, I was an adjunct professor, first at Hofstra Law
School, and then at Fordham Law School. I may have enjoyed
my teaching more than my students did. One time a student
wrote on her evaluation of me that, if her doctor told her that she
had fifteen minutes to live, she wanted to spend all of that time
in Professor Murnane's class because it would seem like an
eternity. Eleanor said that I am supposed to speak for thirty
minutes today, so you will receive a double dose of eternity this
afternoon.
Today's biotechnology conference topics made me dig out my
old college science textbooks. In doing so, I thought about the
hereafter. I went into the attic and wondered, what am I
hereafter, I went down to the basesment and said what am I
hereafter? This morning's symposium was terrific and I applaud
the panel members and organizers for shedding light on such
important topics. I am going to speak in a few moments about
stem cell research but before I do, I want to note that the views
that I am about to express are my own. They are not the views of
the New York Intellectual Property Law Association (NYIPLA),1
an organization of which I am now the president. They are not
the views of the New York State Task Force on Life and the
1 See About the NYIPLA, www.nyipla.org/public/01_about.html (last visited Nov. 15,
2005) (elaborating upon the group, via which patent lawyers voice opinions and concerns
to judiciary).
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Law,2 of which I am a member. They are not the views of my law
firm or any of our clients.
First, permit me to tell you about the New York Intellectual
Property Law Association, also called "NYIPLA," and the task
force. The NYIPLA is a professional association of more than
1,300 attorneys whose interests and practices lie in the areas of
patent, trademark, copyright, trade secret, and other intellectual
property law. 3 NYIPLA members include in-house attorneys
working for businesses that own, enforce, and challenge patents,
as well as attorneys in private practice who represent both
patent owners and accused infringers. 4 NYIPLA members
represent both plaintiffs and defendants in infringement
litigation, and also regularly participate in proceedings before the
United States Patent and Trademark Office, including
representation of applicants for patents. A substantial number of
NYIPLA members participate actively in patent litigation. Due
in part to the concentration of a large number of pharmaceutical
and biotech firms in the New York metropolitan area, significant
numbers of NYIPLA members participate regularly, as
representatives of both traditional research-based "branded"
firms and their newer generic competitors in litigation, involving
claims of infringement. The association's membership includes
attorneys who represent at least four different types of firms that
conduct pharmaceutical and related research and development at
different levels of the industry: first, the major developers of
branded pharmaceuticals; second, the biotech firms; third, the
generic companies; and fourth, the public and private
universities. 5
Now, a few words about the Task Force. The New York State
Task Force on Life and the Law was convened in 1985 under
2 See New York State Department of Health, Task Force on Life and the Law,
www.health.state.ny.us/nysdoh/taskfce/ (last visited Nov. 15, 2005) (describing Task
Force's ability to develop public policy on issues arising from medical advances).
3 See About the NYIPLA, supra note 1 (stating that NYIPLA maintains twenty-four
active committees, of which almost 1500 intellectual property lawyers are members).
4 See id. (noting how the group "was conceived as an organization through which
patent lawyers in New York could make their views known in Washington and provide
support for the judiciary").
5 See id. (adding that the group counts 1500 attorneys amongst its membership).
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then governor Mario Cuomo. 6 The Task Force has a mandate to
develop public policy on a host of issues arising from medical
advances, including: the withholding and withdrawal of life-
sustaining treatment, assisted suicide and euthanasia, assisted
reproductive technology, and organ and tissue transplantation. 7
The Task Force members include leaders in the fields of law,
medicine, nursing, philosophy, and bioethics, as well as patient
advocates and representatives of diverse religious communities.
For each issue that the Task Force addresses, it recommends
policy for New York State in the form of proposed legislation,
regulation, public education, or other measures. The Task Force
reports are designed to explain the bases for its recommendations
and to facilitate public discussion and understanding of the
ethical, social, and legal questions posed by medical advances.
Task Force recommendations have provided the bases for New
York's laws and regulations on the determination of death, do not
resuscitate orders in hospitals and community settings, the
health care proxy, organ and tissue transplantation, and
surrogate parenting.8 Recommendations by the Task Force have
also been embraced as a model for legislation in other states.
Task Force members are appointed by the governor of the State
of New York. 9 As my introduction mentioned, Governor Pataki
appointed me to the Task Force in 1997, while I was a pro bono
appointee of the late John Cardinal O'Connor to the public policy
committee of the New York State Catholic Conference.
The Task Force's assisted reproductive technologies report was
issued during my first year there. One of the issues considered
was cloning. The majority report from April of 1998, in which I
did not join, said,
6 See Exec. Order No. 56, 9 N.Y. Codes R. & Regs. Exec. Dep't. § 4.56 (1984)
(establishing Task Force by Governor Cuomo's Executive Order); Edward A. Adams, New
Law on Medical Treatment Decisions Urged by Task Force, N.Y.L.J., Mar. 24, 1992, at 1
(describing origin of Task Force).
7 See New York State Department of Health, The History of the Task Force,
http://www.health.state.ny.us/nysdoh/taskfce/taskbio.htm (last visited Nov. 15, 2005)
(stating that Task Force is currently only standing state government commission in
United States with mandate to recommend public policy on a range of medical and ethical
issues).
8 See New York State Department of Health, Task Force on Life and the Law Fact
Sheet, http://www.health.state.ny.us/nysdoh/taskfce/factsht.htm (last visited Nov. 15,
2005) (stating that Task Force recommendations have been influential in enactment of
important health related legislation).
9 See Exec. Order No. 56, 9 N.Y. Codes R. & Regs. Exec. Dep't § 4.56 (1984) (stating
that members of the Task Force shall be appointed by the Governor).
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All of us agree that attempting to create a child through
somatic cell nuclear transfer cloning would be ethically
unacceptable at the present time given the existence of the
substantial doubts about the procedure's safety. However,
we hold differing positions on whether it would be ethically
acceptable to use this procedure to create children if and
when the safety concerns are addressed. Because of our
diverse opinions, the fact that the use of this technology is
not yet possible in humans and the likelihood that federal
legislation in this area will soon be enacted, we do not
recommend any legislative or regulatory actions for New
York State at this time.10
Instead, I wrote a minority report, in which I said,
I disagree. Human cloning should be banned. When a sheep
was cloned in Scotland in 1997, many expressed surprise and
fear that human cloning would be possible in the near
future. President Clinton called for national legislation
banning the practice. He urgently reiterated that request in
his weekly radio address to the nation on January 10, 1998,
after a Chicago physician claimed that he would soon be
cloning human beings.11
I went on in my minority report to state that:
Cloning is but the latest chapter in this century's treatment
of human life as a commodity. For if the human winnowing
cultivation practices of fetal reduction are acceptable, one
would expect that human cloning cultivation techniques
would follow not far behind. If the issue is only one of choice,
then the possible choices are limitless. However, human life
is not a commodity, and as a result, should be treated with
more respect than the life of a sheep. Accordingly, I
recommend passage of legislation that bans human cloning
in New York State. 12
Thus far, New York State leaders have not followed my
recommendation. I was encouraged, however, to hear President
Bush express in his State of the Union address earlier this
10 NEW YORK STATE TASK FORCE ON LIFE AND THE LAW, DEPARTMENT OF HEALTH,
ASSISTED REPRODUCTIVE TECHNOLOGIES: ANALYSIS AND RECOMMENDATIONS FOR PUBLIC
POLICY 395 (April 1998).
11 Id. at 462.
12 Id.
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month: "Because society is measured by how it treats the weak
and vulnerable, we must strive to build a culture of life. Medical
research can help us reach that goal."13 President Bush further
stated, "[Medical research can develop] treatments and cures
that save lives and help people overcome disabilities."14 He
continued,
I thank Congress for doubling the funding of the National
Institutes of Health. To build a culture of life, we must
ensure that scientific advances always serve human dignity,
not take advantage of some lives for the benefit of others.
We should all be able to agree on some clear standards.15
Moreover, President Bush also said, "I will work with Congress
to ensure that human embryos are not created for
experimentation or grown for body parts and that human life is
never bought and sold as a commodity."16 He concluded,
"America will continue to lead the world in medical research that
is ambitious, aggressive, and always ethical."17 That State of the
Union address was given on February 2, 2005.
Now, I do not know whether the Task Force on Life and the
Law will take up the question of stem cell research - because it is
controversial. The Task Force usually endeavors to study and
report on topics where consensus can be reached. We are a
cordial and collegial group, and members enjoy productive
working relationships that have been established over the years
during our monthly meetings. We each have our own
perspective, however, and these different views of our many
members would surely be brought to the table if we were to
consider this issue. For my part, I would note that everything I
have read indicates that embryonic stem cell research depends on
human cloning, organ harvesting, and the destruction of innocent
human life. Moreover, it is my understanding that every pending
bill in the New York State Legislature to permit embryonic stem
cell research would also authorize the cloning of human beings.
13 President George W. Bush, State of the Union Address (Feb. 2, 2005), available at
http://www.whitehouse.gov/news/releases/2005/02/20050202-11.html (last visited Nov. 15,
2005).
14 Id.
15 Id.
16 Id.
17 Id.
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The Task Force usually considers background materials
developed and organized by our staff including papers written by
experts in the field. After considering such papers, we hear
presentations during our monthly meetings. We hear a dozen or
so presentations for any issue that we are going to take up. If
such presentations are made to us on this issue, I will inquire
where embryonic stem cell research has been successful. It is my
understanding that, to date, such research has not produced a
single medical benefit. Papers indicate that embryonic stem cells
are unstable and unpredictable because of their immaturity;
furthermore, studies show that they have produced troubling
research results. 1s
I would also ask why we are not focusing on adult stem cell
research. Many publications that I have considered indicate that
adult stem cell and umbilical cord blood research offer a
successful and ethical alternative to destructive embryonic
research.19 I understand that adult and umbilical cord blood
stem cells are currently being used to repair damaged bone and
tissue, reverse the effects of paralysis, treat genetic diseases,
leukemia, and rare diseases affecting the liver, heart, and brain.
Often at Task Force meetings we consider how many other
states are addressing the same or similar issues. Nearly
everyone is familiar with Proposition 71 in California that
established the California Institute for Regenerative Medicine,
which will distribute three hundred million dollars in grants each
year over the next decade for in-state stem cell research. 20 A
coalition of movie stars, universities, venture capitalists, disease
advocacy groups, medical associations, and biotech companies
waged a near thirty million dollar campaign for Proposition 71,
and it passed with fifty-nine percent voter approval in November,
18 See Robert Lee Hotz, Study: Healthy Clones can Carry Hidden Flaws; Stem Cells
Used in Cloning Also Found Unstable, TIMES-PICAYUNE, July 6, 2001, at 6 (citing recent
study that found stem cells unstable).
19 See Sean J. Morrison & Stuart H. Orkin, Stem-Cell Competition, NATURE, July 4,
2002, at 25 (noting that recent studies have shown that adult stem cells can potentially
develop into cells that are different than their tissue of origin, and use of these cells would
eliminate ethical dilemmas associated with embryonic stem cell research).
20 See CAL. CONST. art. XXXV, § 1 (2005) (establishing California Institute of
Regenerative Medicine); CAL. HEALTH & SAF. CODE § 125290.70 (a)(1)(B) (2005) (stating
that no less than 90% of amount of bonds used for grants will be used for research over a
ten year period).
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2004.21 Proponents predicted that stem cell research will yield
California royalty revenues of between $535 million and $1.1
billion. But an article in IP LAW AND BUSINESS just three days
ago said "most biotech IP lawyers say it is foolhardy and wildly
optimistic to predict such royalty revenue will come to California
in the uncertain area of stem cell-derived therapies. 22
What many may not know is that Pennsylvania, which has a
long standing ban on human embryo research, ranks high among
all states in both pharmaceutical and biotechnology
employment. 23 And Michigan, where there are laws banning
cloning and embryo research, is rated as one of the foremost
business-friendly states in the nation. 24  Michigan State
University is considered a leader in biotechnology. 25
Some people say that there are thousands of leftover embryos
in fertility clinics that have no future, and that many of these
embryos will ultimately die anyway. They say that it is a waste
not to use these embryos to promote science. In 2002, the Rand
Corporation conducted a survey of in-vitro fertilization clinics in
the United States. 26 The survey found that there are about
400,000 human embryos currently frozen in fertility clinics.27 Of
21 Carl T. Hall, Proposition 71: State Voters Strongly Backing Cell Research, S.F.
CHRON., Nov. 3, 2004, at B4 (reporting that celebrities such as California Gov. Arnold
Schwarzenegger, Michael J. Fox, and Christopher Reeve supported proposition, and that
advocates of proposition launched a "barrage" of television ads to promote proposition).
22 Victoria Slind-Flor, Will Prop 71 Hold Water?; California's Stem-Cell Initiative May
Not Bring In Expected Patent Royalties, IP LAW & Bus., Feb. 25, 2005, at 2 (suggesting
that vague nature of proposition left uncertain how licensing deals would be structured,
which would make recovering royalties difficult in a short time).
23 PA. CONS. STAT. § 3216(a) (2005) (stating that experimentation on unborn children
outside of abortion and for non-therapeutic purposes is a felony in third degree). See
JUNGHOON KI, ET AL., BIOPHARMACEUTICAL INDUSTRY CONTRIBUTIONS TO STATE & U.S.
ECONOMICS 9-10 (Milken Institute, 2004) (stating that Pennsylvania is one of several
states with high rate of biopharmaceutical employment that is expected to exceed
national average over next decade).
24 RAYMOND J. KEATING, SMALL BuS. SURVIVAL INDEX 2004: RANKING THE POLICY
ENVIRONMENT FOR ENTREPRENEURSHIP ACROSS THE NATION 12 (Small Bus. &
Entrepreneurship Coun. 2004) (noting that, in terms of State government public policy,
Michigan ranks as sixth most friendly state to entrepreneurs in country).
25 Chris Andrews, MSU Wins $3.7 Million to Boost Technology, LANSING STATE J.,
June 30, 2004, at 1B (noting that Michigan State University received $3.7 million dollars
in grants in order to encourage development in biology and chemical engineering).
26 David I. Hoffman, et. al, Cryopreserved Embryos in the United States and Their
Availability for Research, FERTILITY & STERILITY, May 2003, at 1063 (stating that
objective of study is to "determine the number of embryos stored at assisted reproductive
technology clinics in the United States").
27 Id. at 1066-67 (finding that 391,000 frozen embryos were held in storage at clinics
on-site, 4,685 embryos were held off-site, with 340 out of 430 clinics responding to the
survey, and remaining sixty clinics having an estimated embryo count of 51,753).
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the four-hundred-thousand embryos, only a small fraction, 2.8
percent, have been authorized for research. 28 Thus, only about
eleven thousand out of the original four-hundred-thousand frozen
embryos are actually available for research and experimentation.
Of those eleven thousand embryos available for research, it is
likely that only a small number would actually yield stem cells.
The process of freezing, storing and thawing leave the majority of
embryos unable to yield a workable stem cell line. 29
Some say that an embryo is just a bunch of cells, no larger than
the size of a pinhead. The fact is that an embryo is a living
human being. If it were not, it would not be capable of making
human stem cells. Moreover, each and every one of us in this
room was, at one time, just a bunch of cells not larger than the
size of a pinhead. That is how we all start.
If we have an opportunity as Task Force members to consider
this issue, I will ask presenters their views about research at the
University of California in San Diego where patients' adult skin
cells have been used to cut in half the progression of the mental
decline from Alzheimer's disease. 30 Other published research
shows that bone marrow stem cells could be useful in treating
neuro-degenerative disorders. 31 I will also ask about the reports
of German doctors that have grown a new jawbone from bone
marrow stem cells to replace a man's lower jaw lost to cancer. 32 I
understand that bone marrow stem cells are also being used by
doctors to construct cartilage in damaged and arthritic joints.
28 Id. (concluding that 3% of the embryos in storage at participating clinics were held
for research, with almost 4% for unknown or miscellaneous reasons, and less than 2.5% of
embryos that were stored off-site were held for medical research and experimentation,
with none being held for miscellaneous reasons).
29 Id. at 1068 (stating that even if all embryos were available for stem cell research,
only 275 stem cell lines would be created, using conservative estimates).
30 Betsy Mason, New Approach on Stem Cells: Researchers Say Use Of Adult Cells
Bypasses Ethical Obligations, TIMES UNION, Nov. 22, 2004, at A6 (stating that one
University of California bioengineer has discovered method to use protein called "Sonic
hedgehog"' in mice brains to speed division of brain stem cells, which can potentially
enhance functions of those brain damaged by Alzheimer's Disease).
31 Karen J. Chandross, et al., Turning Blood into Brain: Cells Bearing Neuronal
Antigens Generated in Vivo from Bone Marrow, SCIENCE, Dec 1, 2000, at 1779, 1781
(suggesting that experiments involving mice indicate that bone marrow stem cells can
supply alternative sources of neural cells, which can provide accessibility and
compatibility for its host).
32 Transplant Medicine: German Doctors Grow New Jaw Bone in Man's Back Muscle
for Transplantation, MED. & L. WKLY., Sept. 17, 2001, at 310 (stating that doctors used
patient's bone marrow, a growth chemical, and one mesh cage to grow his new jaw bone in
his back muscle and transplant it to his mouth).
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Further, I have read that researchers use stem cells from
human fat to grow human bone cells and heal large cranial
defects in animals. 33
Umbilical cord blood stem cells have been shown to reduce
brain damage in stroke victims. 34 Skin cells and bone marrow
cells have also shown promise in treating stroke victims. Bone
marrow and umbilical cord blood transplants are being
successfully used to treat and cure leukemia and other fatal
cancers. 35 Researchers have used adult stem cells to cure
diabetes in mice and are currently working to apply the
treatment in humans. 36 Adult stem cells can improve vision in
eyes damaged by retinal disease. Doctors in Japan have
succeeded in restoring the sight of patients by using the patient's
own oral mucous membrane. 37 And in research promising to
millions of people with hearing loss, scientists have regenerated
hearing in mature mammals using adult stem cells.3 S
To continue, bone marrow stem cells can be used to repair the
heart from heart attack damage and blocked arteries. Doctors
have used bone marrow stem cells to completely repair the heart
33 Anjana Ahuja, A Good Fix From Fat, TIMES (ENG.), May 13, 2004, at 14 (reporting
that adipose-derived adult stromal cells repaired cranial defects of mice as well as bone
marrow, seven times as fast).
34 Medical College of Georgia: Umbilical Cord Blood-Derived Stem Cells Given
Intravenously Reduce Stroke Damage, L. & HEALTH WKLY, Oct. 23, 2004, at 216 (noting
"[s]tem cells taken from umbilical cord blood, then given intravenously along with a drug
known to temporarily breach the brain's protective barrier, can dramatically reduce
stroke size and damage, Medical College of Georgia (MCG) and University of South
Florida (USF) researchers say").
35 See Funding (NIH): Grants for Umbilical Cord Blood Transplants and AIDS Gene
Therapy Awarded, AIDS WKLY, Oct. 20, 1997, at 13-14 (quoting Walter C. Ogier, Vice
President Marketing at Aastrom as saying "[t]he umbilical cord blood transplant grant
marks recognition of the Aastrom CPS' potential expanded utility for stem cell therapy in
treating patients with leukemia and related types of cancer").
36 See Nicholas Wade, Teaching the Body To Heal Itself; Work on Cells' Signals
Fosters Talk of a New Medicine, N.Y. TIMES, Nov. 7, 2000, at Fl (noting "in mice,
researchers were able to reverse a type of diabetes by implanting cells generated from
pancreatic stem cells").
37 See Karen Hoy, Miracle Op Restores Grandfather's Sight, UK NEWSQUEST
REGIONAL PRESS, Dec. 29, 2003 (reporting on procedure to restore man's sight, which his
doctor learned in Hong Kong, where initial step is described as "superficial scar tissues
over the cornea are removed and the whole eye surface covered with thick mucous
membrane taken from inside the patient's cheek").
38 See Marine Biological Laboratory; Listen Up! Mice May Hold Key to Restoring
Human Hearing Loss, MANAGED CARE L. WKLY, Sept. 19, 2004, at 53 (reporting scientists
have developed "new methods to expand and maintain adult stem cells isolated from the
mouse inner ear to establish long-term stable cell lines. This is the first step toward the
ultimate goal of creating implantable human hair cells that will grow happily, eventually
repairing damaged hearing and restoring balance").
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of a sixteen-year-old boy in Michigan who was shot through the
heart with a nail gun.39 Researchers at the University of Chicago
have determined how to transform adult bone marrow stem cells
into immune system cells, called "B cells," that produce
antibodies and fight infection.40 Researchers at the University of
Michigan Health System have used bio-artificial kidneys, made
of human adult stem cells, which show great potential to save the
lives of people with acute renal failure in human studies. 41 Other
published studies show bone marrow stem cells can likely treat
acute renal failure, injured kidneys, and repair liver damage in
humans. 42
Researchers at Johns Hopkins have used adult stem cells from
mice to delay symptoms and death resulting from Lou Gehrig's
disease. 43 Researchers at Yale have used adult bone marrow
stem cells to regenerate important nerve cells destroyed by
multiple sclerosis. 44 Research shows that adult blood stem cells
can contribute to muscle regeneration in neuromuscular diseases
like muscular dystrophy.45 Researchers at Jefferson Medical
39 See generally Federal Funding of Human Embryonic Stem Cell Research - Illegal,
Unethical and Unnecessary, 18 J. CONTEMP. HEALTH L. & POL'Y 95, 131-32 (2001) (noting
"researchers found that by stimulating production of stem cells in the bone marrow of
adult mice, one can repair heart damage").
40 See Michael Greer, Rheumatoid Arthritis: Bone Marrow Stem Cells Involved In
Pathogenesis, BLOOD WKLY, Aug. 22, 2002, at 8 (discussing proposition that "bone marrow
stem cells from osteoarthritis patients differentiated into MLCs with similar effects on B
cells").
41 See Bioengineers Create Working Cow Kidneys, MEMBRANE & SEPARATION TECH.
NEWS, Aug. 2002 (noting "bioengineers at Advanced Cell Technology have created
working artificial kidneys using cells taken from cloned cow embryos seeded onto
polycarbonate membranes").
42 See Stem Cell Transplantation: Bone Marrow Produces Mature Liver Cells in
Humans, HEPATITIS WKLY, July 3, 2000, at 9-10 (finding "mature liver cells in humans
are generated from bone marrow-derived stem cells, a Yale University-New York
University team has discovered, paving the way for improved treatment of liver damage
and disease").
43 See Stem Cell: Experiment Returns Motion to Paralyzed Rodents, AM. HEALTH
LINE, July 25, 2001 (reporting "a Johns Hopkins University study in which paralyzed
rodents regained mobility after having embryonic stem cells implanted into their spinal
cords demonstrates that stem cell research has 'moved beyond 'potential' to meaningful
results"').
44 See Multiple Sclerosis: Stem Cell Transplants May Be Effective Therapy, PAIN &
CENTRAL NERVOUS SYSTEM WEEK, May 6, 2002, at 16 (noting a new treatment for
multiple sclerosis is "removing stem cells from the patient's blood, killing the cells that
are working against the body's immune system and then returning the healthy cells back
to the body").
45 See Muscular Dystrophy: Stem Cells May Offer Cure For Fatal Muscular
Dystrophy, PAIN & CENTRAL NERVOUS SYSTEM WEEK, August 19, 2002, at 6 (noting that
scientists "were able to isolate a specific type of adult stem cell from the muscles of mice.
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College have coaxed bone marrow stem cells into dopamine-
producing neurons, a study which shows great potential in
treating neurological diseases like Parkinson's disease.46
Stem cells from umbilical cord blood are currently being used
to cure and treat sickle cell anemia.
Doctor Carlos Lima of Peru has treated over thirty spinal cord
injury patients with an experimental surgery that injects adult
stem cells from the nasal cavity into the spinal cord. 47 Some
patients have experienced restored bladder function, regained
complete function of paralyzed arms, and can now stand and
walk with the aid of braces. No patient there has displayed any
negative side effects.
Researchers in Korea report that they have enabled a patient
paralyzed for nineteen years to walk again with stem cells from
umbilical cord blood injected into the damaged spinal cord. 48
Researchers at the University of Washington have shown that
bone marrow stem cells help fight infection and permanently
heal wounds.49 British scientists have developed live bandages
made from a patient's own stem cells which speed healing for
burns and diabetes sufferers.50
The literature is filled with adult stem cell research success
stories. But few of these reports appear in major newspaper,
television, or radio news stories. As a Task Force member, I
The cells can replace degenerate muscular tissue in mice suffering from muscular
dystrophy, doing this better than has hitherto been possible with other cells").
46 See Neurodegenerative Disease: Human Neural Stem Cells Transformed To
Dopamine-Making Brain Cells, PAIN & CENTRAL NERVOUS SYSTEM WEEK, Dec. 2, 2002, at
8 (reporting scientists at Jefferson Medical College have discovered "mouse neural stem
cells placed in rats with Parkinson disease could develop into brain cells that produced
tyrosine hydroxylase (TH), the enzyme needed to make dopamine").
47 PBS, Innovation: Life Inspired: Episode 6: Miracle Cell Summary, http://www.
pbs.org/wnetlinnovation/about-episode6.html (last visited Nov. 15, 2005) ("Dr. Lima
oversees a group of surgeons in the harvesting of patients' stem cells from their noses.
The cells are then transplanted into the sites of the spinal cord breaks.").
48 Paralyzed Woman Walks Again After Stem Cell Therapy, http://www.cogforlife.
org/stemcellumbilical.htm (last visited Nov. 15, 2005) (reporting that "a South Korean
woman paralyzed for 20 years is walking again after scientists say they repaired her
damaged spine using stem cells derived from umbilical cord blood").
49 See Therapy: Adult Bone Marrow Stem Cells Can Become Blood Vessels, STEM CELL
WEEK, Mar. 11-18, 2002, at 5 (stating "researchers at the University of Minnesota Stem
Cell Institute (SCI) have demonstrated, for the first time, the ability of adult bone marrow
stem cells to expand in vitro as endothelial cells (which line blood and lymphatic vessels)
and then engraft in vivo and contribute to new growth of blood vessels").
50 See Celltran: Skin Cell Bandages For Burns Developed, LAB BUS. WEEK, May 23,
2004, at 36 (explaining "[a] sample of the patient's skin, usually from the thigh, is taken
under local anesthetic and the cells are then expanded many hundred-fold in the
laboratory before being placed on the bandage").
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would try to ensure that all of us considered a complete record
before developing recommendations for our state. A voice far
more eloquent than mine will be speaking on this subject very
soon in Albany: on Tuesday, March 8th, 2005, paralyzed New
York City police detective Steven McDonald will be the featured
speaker at the New York State Catholic Conference's Public
Policy Forum in Albany.51 Detective McDonald, who was shot in
the line of duty in 1986 and left quadriplegic,52 rejects the use of
human embryos for medical experimentation; instead, he favors
research involving adult and umbilical cord stem cells. My hope
is that many lawmakers hear Detective McDonald that day and
that the news organizations which will be covering the event tell
us what he says.
Thank you again for permitting me to speak with you today.
51 See Joe Mahoney, Paralyzed Cops Split Over Bill On Stem Cells, DAILY NEWS, Mar.
7, 2005, at 5 (noting "McDonald, 48, will be alongside Edward Cardinal Egan and a
brigade of Catholic bishops lobbying for a state ban on the research because, they say, it
amounts to killing human life").
52 Id. (explaining "[iun July, 1986, while patrolling Central Park, McDonald was shot
three times after confronting three teens stealing bikes. One bullet lodged in his spine").
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